122 related articles for article (PubMed ID: 11342427)
1. Mimicry between neurokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis.
Rameshwar P; Joshi DD; Yadav P; Qian J; Gascon P; Chang VT; Anjaria D; Harrison JS; Song X
Blood; 2001 May; 97(10):3025-31. PubMed ID: 11342427
[TBL] [Abstract][Full Text] [Related]
2. Synergism between fibronectin and transforming growth factor-β1 in the production of substance P in monocytes of patients with myelofibrosis.
Chang VT; Yook C; Rameshwar P
Leuk Lymphoma; 2013 Mar; 54(3):631-8. PubMed ID: 22906243
[TBL] [Abstract][Full Text] [Related]
3. Substance p-fibronectin-cytokine interactions in myeloproliferative disorders with bone marrow fibrosis.
Rameshwar P; Oh HS; Yook C; Gascon P; Chang VT
Acta Haematol; 2003; 109(1):1-10. PubMed ID: 12486316
[TBL] [Abstract][Full Text] [Related]
4. Structural similarity between the bone marrow extracellular matrix protein and neurokinin 1 could be the limiting factor in the hematopoietic effects of substance P.
Rameshwar P; Gascon P; Bandari PS; Joshi DD; Fernandes A; Dang A
Can J Physiol Pharmacol; 2002 May; 80(5):475-81. PubMed ID: 12056556
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P.
Bandari PS; Qian J; Yehia G; Joshi DD; Maloof PB; Potian J; Oh HS; Gascon P; Harrison JS; Rameshwar P
Regul Pept; 2003 Mar; 111(1-3):169-78. PubMed ID: 12609765
[TBL] [Abstract][Full Text] [Related]
6. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex.
Macdonald D; Mierke DF; Li H; Pellegrini M; Sachais B; Krause JE; Leeman SE; Boyd ND
Biochemistry; 2001 Feb; 40(8):2530-9. PubMed ID: 11327875
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines.
Rameshwar P; Poddar A; Gascón P
Leuk Lymphoma; 1997 Dec; 28(1-2):1-10. PubMed ID: 9498698
[TBL] [Abstract][Full Text] [Related]
8. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.
Bremer AA; Leeman SE; Boyd ND
FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody directed against the neurokinin-1 receptor contains a peptide sequence with similar hydropathy and functional properties to substance P, the natural ligand for the receptor.
Sagot MA; Wijkhuisen A; Créminon C; Tymciu S; Frobert Y; Turbica I; Grassi J; Couraud JY; Boquet D
Mol Immunol; 2000 Jun; 37(8):423-33. PubMed ID: 11090877
[TBL] [Abstract][Full Text] [Related]
10. Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma.
Rameshwar P; Gascón P
Blood; 1996 Jul; 88(1):98-106. PubMed ID: 8704207
[TBL] [Abstract][Full Text] [Related]
11. Calpha methylation in molecular recognition. Application to substance P and the two neurokinin-1 receptor binding sites.
Sagan S; Lequin O; Frank F; Convert O; Ayoub M; Lavielle S; Chassaing G
Eur J Biochem; 2001 May; 268(10):2997-3005. PubMed ID: 11358518
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the second extracellular loop (E2) of the neurokinin-1 receptor in the binding of substance P. Photoaffinity labeling and modeling studies.
Lequin O; Bolbach G; Frank F; Convert O; Girault-Lagrange S; Chassaing G; Lavielle S; Sagan S
J Biol Chem; 2002 Jun; 277(25):22386-94. PubMed ID: 11950831
[TBL] [Abstract][Full Text] [Related]
13. Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers.
Brunelleschi S; Nicali R; Lavagno L; Viano I; Pozzi E; Gagliardi L; Ghio P; Albera C
Neuropeptides; 2000 Feb; 34(1):45-50. PubMed ID: 10688968
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of substance P transport across the blood-brain barrier.
Chappa AK; Audus KL; Lunte SM
Pharm Res; 2006 Jun; 23(6):1201-8. PubMed ID: 16729222
[TBL] [Abstract][Full Text] [Related]
15. Receptor induction regulates the synergistic effects of substance P with IL-1 and platelet-derived growth factor on the proliferation of bone marrow fibroblasts.
Rameshwar P; Poddar A; Zhu G; Gascón P
J Immunol; 1997 Apr; 158(7):3417-24. PubMed ID: 9120302
[TBL] [Abstract][Full Text] [Related]
16. Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor.
Seelig A; Alt T; Lotz S; Hölzemann G
Biochemistry; 1996 Apr; 35(14):4365-74. PubMed ID: 8605185
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
Vigna SR
Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
[TBL] [Abstract][Full Text] [Related]
18. The peptide binding site of the substance P (NK-1) receptor localized by a photoreactive analogue of substance P: presence of a disulfide bond.
Boyd ND; Kage R; Dumas JJ; Krause JE; Leeman SE
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):433-7. PubMed ID: 8552654
[TBL] [Abstract][Full Text] [Related]
19. The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor.
Girault S; Sagan S; Bolbach G; Lavielle S; Chassaing G
Eur J Biochem; 1996 Aug; 240(1):215-22. PubMed ID: 8797856
[TBL] [Abstract][Full Text] [Related]
20. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction.
Rameshwar P; Gascón P
Blood; 1995 Jul; 86(2):482-90. PubMed ID: 7541664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
